Clinical validation of a new commercial highly sensitive KIT D816V mutation analysis in mastocytosis
- 1 June 2020
- Vol. 75 (6), 1489-1491
- https://doi.org/10.1111/all.14165
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Towards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-bloodLeukemia & Lymphoma, 2018
- Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosisAllergy, 2017
- Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patientsAmerican Journal of Hematology, 2016
- Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implicationsLaboratory Investigation, 2015
- KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisLeukemia, 2015
- Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on MastocytosisAllergy, 2014
- Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosisAmerican Journal of Hematology, 2014
- Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR AssayThe Journal of Molecular Diagnostics, 2011